StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Total gross debt by Quarter

Total gross debt (loans, bonds, overdrafts & lease liabilities) ($M) ($M)

QuarterlyAnnual

AstraZeneca Total gross debt: -$32,239M in Q2 2026, down 1.8% from a year earlier.

Latest, Q2 2026
-32,239
Period ended Jun 30, 2026
Change on a year earlier
-1.8%
-32,839 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| Interest-bearing loans and borrowings (Gross debt) | (32,239) | (29,622) | (32,839)”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Net Debt Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal gross debt (loans, bonds, overdrafts & lease liabilities) ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026-32,239-1.8%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026-33,918+7.2%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025-29,622-2.2%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025-32,632+3.4%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025-32,839-2.1%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025-31,646-8.4%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024-30,295+5.8%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024-31,562+10.4%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024-33,533+12.4%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024-34,551+9.7%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023-28,622-2.1%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023-28,576-2.5%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023-29,838+1.0%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 2023-31,503+1.3%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022-29,232-5.0%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022-29,299-8.2%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up total gross debt

Cite this data

StockData. (2026). AstraZeneca Total gross debt ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/nd-gross-debt

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.